Alzheimer’s breakthrough could be ‘beginning of the end’: drug study
Alzheimer’s disease could soon be a distant memory. A revolutionary new Alzheimer’s drug named lecanemab could mark a major breakthrough in the decades-long battle against the neurological disorder, according to eye-opening Phase 3 trials. The potentially game-changing dry runs transpired in May 2021, but the results were only published Tuesday in the New England Journal … Read more